List of Excipients in API sevelamer hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sevelamer hydrochloride
Excipients in ANDA-approved (generic) drugs containing sevelamer hydrochloride
Detailed excipient profiles for sevelamer hydrochloride
Excipient focus: AMMONIA
sevelamer hydrochloride drug variants containing AMMONIA
sevelamer hydrochloride drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Winthrop US a business of sanofi-aventis US LLC | sevelamer hydrochloride | 0955-1048 |
| Genzyme Corporation | sevelamer hydrochloride | 58468-0020 |
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
sevelamer hydrochloride drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sevelamer hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | sevelamer hydrochloride | 33342-241 |
| Aurobindo Pharma Limited | sevelamer hydrochloride | 59651-087 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSPOVIDONE
sevelamer hydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sevelamer hydrochloride | 59651-087 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: DIACETYLATED MONOGLYCERIDES
sevelamer hydrochloride drug variants containing DIACETYLATED MONOGLYCERIDES
sevelamer hydrochloride drug variants not containing DIACETYLATED MONOGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
sevelamer hydrochloride drug variants containing FERROSOFERRIC OXIDE
sevelamer hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIBEHENATE
sevelamer hydrochloride drug variants containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sevelamer hydrochloride | 59651-087 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing GLYCERYL DIBEHENATE
Excipient focus: HYDROXYPROPYL CELLULOSE
sevelamer hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sevelamer hydrochloride | 59651-087 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
sevelamer hydrochloride drug variants containing HYPROMELLOSE
sevelamer hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | sevelamer hydrochloride | 33342-241 |
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
sevelamer hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
sevelamer hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | sevelamer hydrochloride | 33342-241 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
sevelamer hydrochloride drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
sevelamer hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MANNITOL
sevelamer hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing MANNITOL
Excipient focus: POLYETHYLENE GLYCOL 3350
sevelamer hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 6000
sevelamer hydrochloride drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYVINYL ALCOHOL
sevelamer hydrochloride drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sevelamer hydrochloride | 70748-172 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: PROPYLENE GLYCOL
sevelamer hydrochloride drug variants containing PROPYLENE GLYCOL
sevelamer hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Winthrop US a business of sanofi-aventis US LLC | sevelamer hydrochloride | 0955-1048 |
| Genzyme Corporation | sevelamer hydrochloride | 58468-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
sevelamer hydrochloride drug variants containing SHELLAC
sevelamer hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Winthrop US a business of sanofi-aventis US LLC | sevelamer hydrochloride | 0955-1048 |
| Genzyme Corporation | sevelamer hydrochloride | 58468-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sevelamer hydrochloride drug variants containing SILICON DIOXIDE
sevelamer hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
sevelamer hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
sevelamer hydrochloride drug variants containing STEARIC ACID
sevelamer hydrochloride drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sevelamer hydrochloride | 59651-087 |
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
sevelamer hydrochloride drug variants containing TALC
sevelamer hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Winthrop US a business of sanofi-aventis US LLC | sevelamer hydrochloride | 0955-1048 |
| Macleods Pharmaceuticals Limited | sevelamer hydrochloride | 33342-241 |
| Genzyme Corporation | sevelamer hydrochloride | 58468-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC STEARATE
sevelamer hydrochloride drug variants containing ZINC STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sevelamer hydrochloride | 60687-449 |
| Glenmark Pharmaceuticals Inc USA | sevelamer hydrochloride | 68462-446 |
| NorthStar RxLLC | sevelamer hydrochloride | 72603-148 |
| >Company | >Ingredient | >NDC |
sevelamer hydrochloride drug variants not containing ZINC STEARATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
